Specific polypeptide related to rheumatoid arthritis and application thereof
A specific, arthritic technology for rheumatoid arthritis detection that addresses inefficiencies and unsatisfactory results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0091] Example 1: Design and synthesis of polycitrulline similar amino acid repeat structure (Multi-Cirtrullin Similar Motif, MCSM) polypeptide:
[0092] The designed peptide sequence is as follows:
[0093] P01: HQDQG(Cit)S(Cit)NRAA (SEQ ID NO.: 1)
[0094] P02: DCDGQW(Cit)GP(Cit)SVE(Cit)HQSAKCK (SEQ ID NO.: 2)
[0095] P03: KCKQFRN(Cit)G(Cit)SPRAADCD (SEQ ID NO.: 3)
[0096] P04: HQCHQESTRGRSRGRCGRSGS (SEQ ID NO.: 4)
[0097] P05: SHQEST(Cit)G(Cit)SRG(Cit)SG(Cit)SGS (SEQ ID NO.: 5)
[0098] P06: HQDNQ(Cit)S(Cit)QNAA (SEQ ID NO.: 6)
[0099] P07: HQGQG(Cit)G(Cit)SQGQGRA (SEQ ID NO.: 7)
[0100] P08: HNGNG(Cit)G(Cit)SNGRGNA (SEQ ID NO.: 8)
[0101] P10: HANN(Cit)T(Cit)SNNGA (SEQ ID NO.: 9)
[0102] P11: RSQFNW(Cit)S(CIT)SRPR (SEQ ID NO.: 10)
[0103] P12: HQFRN(Cit)Q(Cit)RSRNHA (SEQ ID NO.: 11)
[0104] P13: HQYNFQW(Cit)S(Cit)GRPR (SEQ ID NO.: 12)
[0105] P14: GRFQM(Cit)H(Cit)RLIRH (SEQ ID NO.: 13)
[0106] P15: RSQFNF(Cit)P(Cit)SRPR (SEQ ID NO.: 14)
[0107] P16:...
Embodiment 2
[0112] Example 2: Comparison of different citrullinated and MSCM polypeptides to detect differences in anti-citrullinated antibodies in human serum
[0113] Experimental Materials:
[0114] ELISA plate: NUNC446469
[0115] Streptavidin: Hangzhou New Dragon rc-SA
[0116] Coating buffer: PBS, pH7.4
[0117] Washing solution: PBS+Triton X-100, pH7.4
[0118] Blocking solution: PBS+1%BSA, pH7.4
[0119] Sample diluent: PBS+0.1%Triton X-100+1%BSA
[0120] Enzyme-labeled antibody: HRP-labeled mouse anti-human IgG (for 1:15000)
[0121] Enzyme-labeled antibody diluent: PBS+1%BSA+0.1%Triton X-100, pH7.4
[0122] Different biochemical peptides:
[0123] P04 (no citrullination)
[0124] P05 (with citrullination, without MSCM characteristic conformation)
[0125] P11 (citrullinated, MSCM characteristic conformation)
[0126] P18 (with citrullination, MSCM characteristic conformation)
[0127] Omon CCP
[0128] sample:
[0129] Healthy control: 20 cases
[0130] RA, Eumont CC...
Embodiment 3
[0175] Example 3: Synthetic polypeptides were cross-linked with BSA, after purification, rabbits were immunized to produce polyclonal antibodies
[0176] 1) The synthetic polypeptide is coupled to the carrier protein BSA or OVA by EDC method or glutaraldehyde cross-linking method;
[0177] 2) Select two healthy 6-week-old New Zealand white rabbits (about 2Kg);
[0178] 3) Fully mix 1ml of Freund's complete adjuvant with the prepared 1ml of antigen, and it becomes milky white;
[0179] 4) 400ug antigen for the first immunization, 100ug each time for subsequent immunization; subcutaneous injection on the back;
[0180] 5) Immunize once every two weeks, a total of 4 to 5 times, and finally collect blood after verifying that the antibody concentration in the serum reaches the standard;
[0181] 6) Antibodies in serum were purified using ProteinA / G affinity packing.
[0182] The purified polyclonal antibody combined with one or more antibodies against vimentin, fibrinogen, type ...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com